<html><body><table class="support-info__table table article-section__table"> <thead> <th id="article-filename" scope="col">Filename</th> <th id="article-description" scope="col">Description</th> </thead> <tbody> <tr id=""> <span style="color:red" title="HPO: HP:0002981
LABEL: FP
CONF: 0.81171274
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" ></span>  <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fhumu.23205&amp:file=humu23205-sup-0001-SuppMat.docx">humu23205-sup-0001-SuppMat.docx</a>17.4 MB                            </td> <span style="color:lime" title="HPO: HP:0001252
LABEL: TP
CO <span style="color:lime" title="HPO: HP:0001511
LABEL: TP
CONF: 0.9977375
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" >NF: 0.9229314
PAT: None
NEG: 0.0</span> 
REL: 1. <span style="color:lime" title="HPO: HP:0001249
LABEL: TP
CONF: 0.9938634
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" >0
SECTION: ReportBialle</span> lic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" ></span>  <td headers="article-description"><p><b>Supp. Figure S1</b>: Result of whole genome parametric (Merlin) linkage analysis for family 1.</p> <p><b>Supp. Figure S2</b>: Electropherograms from Sanger confirmation in members of family 1, (A) showing <i>SARS</i>: c.514G&gt:A, and (B) <i>ZNF697</i>: c.472C&gt:A, heterozygous and homozygous sequences.</p> <p><b>Supp. <span style="color:red" title="HPO: HP:0002981
LABEL: FP
CONF: 0.81171274
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" ></span>  Figure S3</b>: <i>SARS</i> expression (readcounts) de <span style="color:red" title="HPO: HP:0008846
LABEL: FP
CONF: 0.9618845
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" >termined by RNA‐sequencing of various  <</span> span style="color:lime" title="HPO: HP:0012443
LABEL: TP
CONF: 0.82531583
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Table File 1" >brai </span> <span style="color:lime" title="HPO: HP:0001249
LABEL: TP
CONF: 0.9938634
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" >n tissues.</p> <span st</span> yle="color:lime" title="HPO: HP:0001252
LABEL: TP
CONF: 0.9229314
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" ></span>  <p><b>Supp. Figure S4</b>: SARS active site. <span style="color:lime" title="HP <span style="color:lime" title="HPO: HP:0001397
LABEL: TP
CONF: 0.99195975
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" >O: HP:000</span> 1399
LABEL: TP
CONF: 0.9852403
PAT: None
NEG: 0.0
REL: 1.0
SECTION: ReportBiallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy" ></span>  (A) Residues p.His170 (H170, dark  <span style="color:lime" title="HPO: HP:0001510
LABEL: TP
CONF: 0.9510399
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >blue) and F316/38</span> 3 (orange) stabilize a β‐sheet of the aminoacylation domain. p.Asp172 (D172, red) faces away from the aminoacylation core, but is located directly adjacent to the N‐terminus of the UNE‐S domain (yellow). Light blue: ATP binding sites: pink: serine binding sites. <span style="color:lime" titl <span style="color:red" title="HPO: HP:0002981
LABEL: FP
CONF: 0.81171274
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >e="H</span> PO: HP:0001510
LABEL: TP
CONF: 0.8006810999999999
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" ></span>  Orientation of (B) wild type p.Asp172 (D172, green) and (C) mutant p.Asn172 (N172, red). The nuclear localization signal (NLS) is located seven amino acids downstream of p.Pro475 (P475, yellow).</p> <p><b>Supp. Figure S5</b>: WARS2 expression (readcounts) determined by RNA‐sequencing of various  <span style="color:lime" title="HPO: HP:0012443
LABEL: TP
CONF: 0.82531583
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Table File 1" >brain</span>  tissues.</p> <p><b>Supp. < <span style="color:lime" title="HPO: HP:0001510
LABEL: TP
CONF: 0.90032685
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >span style="color:lime" title="HP</span> O: HP:0001392
LABEL: TP
CONF: 0.9758091
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" ></span>  <span style="color:lime" title="HPO: HP:0001392
LABEL: TP
CONF: 0.9758091
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" ></span>  Figure S6</b>: Electropherograms from Sanger confirmation in members of family 2, showing <i>WARS2</i>: c.37T&gt:G and c325delA sequences. Father and mother show heterozygous sequences for the frameshift and the missense change, respectively.The patients show het <span style="color:red" title="HPO: HP:0002981
LABEL: FP
CONF: 0.81171274
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" >eroz</span> ygous sequences for both mutations.</p> <p><b>Supp. <span style="col <span style="color:lime" title="HPO: HP:0001511
LABEL: TP
CONF: 0.9968729
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" >or:lime" title="HPO: HP:0001392
L</span> ABEL: TP
CONF: 0.8399474
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" ></span>  Figure S7</b>: EYFP‐WARS2 wild type and mutant localize in the mitochondria (Control of mitochondrial fractionation). <span style="color:l <span style="color:lime" title="HPO: HP:0001511
LABEL: TP
CONF: 0.9968729
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" >ime" title="HPO: HP:0000407
LABEL</span> : TP
CON <span style="color:lime" title="HPO: HP:0001249
LABEL: TP
CONF: 0.9938634
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" >F: 0.9849287
PAT: None
</span> NEG: 0.0 <span style="color:lime" title="HPO: HP:0001252
LABEL: TP
CONF: 0.9229314
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" >
REL: 1.0
SECTION:</span>  Main Text" ></span>  <span style="color:l <span style="color:lime" title="HPO: HP:0001397
LABEL: TP
CONF: 0.99195975
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" >ime" titl</span> e="HPO: HP:0000819
LABEL: TP
CONF: 0.9600735
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" ></span>  Protein lysate from mitochondrial fraction (MT), cytosolic fraction (CF) from HEK293T cells transfected either with EYFP‐WARS2 wild type (WT) or mutant (p.Trp13Gly) were run on SDS‐PAGE. The gel was blotted and probed with an α‐GFP antibody. The blot was subsequently probed with α‐tubulin and α‐PHB1 (mitochondrial marker) antibodies as l <span style="color:lime" title="HPO: HP:0001263
LABEL: TP
CONF: 0.824989
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >oading controls for</span>  cytosolic and mitochondrial fractions, respectively.</p> <p><b>Supp. <span style="color:red" title="HPO: HP:0007015
LABEL: FP <span style="color:lime" title="HPO: HP:0001511
LABEL: TP
CONF: 0.99550664
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" >
CON</span> F: <span style="color:lime" title="HPO: HP:0001511
LABEL: TP
CONF: 0.9979231
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Main Text" > 0.8629382999999999
PAT: None
N</span> EG: 0.0
REL: 1.0
SECTION: Main Text" ></span>  Figure S8</b>: Immunofluorescence analysis, using a specific antibody  <span style="color:lime" title="HPO: HP:0012443
LABEL: TP
CONF: 0.82531583
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >again</span> st SDHA on cells overexpressing EYFP‐WARS2 wild type (WT), compared to cells overexpressing the mutant protein (p.Trp13Gly) and control. In the cells overexpressing WT‐WARS2 (cells with green signal, upper panel) a strong reduction of endogenous SDHA signal is visible (red signal in the corresponding cells, upper panel) in comparison to those expressing p.Trp13Gly.</p> <p><b>Supp. Table S1</b>: Primers for amplif <span style="color:lime" title="HPO: HP:0001511
LABEL: TP
CONF: 0.9979231
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" >ication of <i>SARS</i> and <i>W</span> ARS2</i> genes.</p> <p><b>Supp.  <span style="color:lime" title="HPO: HP:0025356
LABEL: TP
CONF: 0.99174535
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" ><span style="color:lime</span> "  <span style="color:lime" title="HPO: HP:0001252
LABEL: TP
CONF: 0.9229314
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" >title="HPO: HP:000</span> 1508
L <span style="color:lime" title="HPO: HP:0011968
LABEL: TP
CONF: 0.9908641
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" >ABEL: TP
CON</span> F: 0.95105726
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" ></span>  Table S2</b>: Primers for mutagenesis and cloning of <i>SARS</i> and <i>WARS2</i> in different expression vectors.</p> <p><b>Supp. <span style="color:red" title="HPO: HP:0011282
 <span style="color:lime" title="HPO: HP:0012443
LABEL: TP
CONF: 0.82531583
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >LABEL</span> : FP
CONF: 0.9552043
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" ></span>  Table S3</b>: Variants identified by whole‐exome sequencing in one affected (V:7) from family 2.</p> </td> <span style="color: <span style="color:lime" title="HPO: HP:0001263
LABEL: TP
CONF: 0.9974731
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >lime" title="HPO: HP</span>  < <span style="color:lime" title="HPO: HP:0012443
LABEL: TP
CONF: 0.8536671
PAT: None
NEG: 0.0
REL: 1.0
SECTION: Captions" >span style="col</span> or:red" title="HPO: HP:0040194
LABEL: FP
CONF: 0.9756001
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" >:0001510
LABEL: TP
CONF: 0.9</span> 571613
PAT: #65269
NEG: 0.0
REL: 1.0
SEC <span style="color:lime" title="HPO: HP:0003073
LABEL: TP
CONF: 0.99461
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" >TION: Main Text</span> " ></span>   <span style="color:lime" title="HPO: HP:0001263
LABEL: TP
CONF: 0.99591064
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" ></tr></span>  </tbody> <span style="color:red" title="HPO: <span style="color:lime" title="HPO: HP:0001344
LABEL: TP
CONF: 0.9017795
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" > HP:0007015
LABEL: FP
CON</span> F: 0.8629382999999 <span style="color:lime" title="HPO: HP:0010864
LABEL: TP
CONF: 0.993394
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" >999
PAT: #65269
NEG: 0.0
REL: </span> 1. <span style="color:lime" title="HPO: HP:0001252
LABEL: TP
CONF: 0.9229314
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" >0
SECTION: Main Te</span> xt" ></span>  <span style="color:lime" title="HPO: HP:0001257
LABEL: TP
CONF: 0.9826288
PAT: #65269
NEG: 0.0
REL: 1.0
SECTION: Main Text" ></span>  </table></body></html>